HOME        EBOOK/WHITE PAPERS        VIDEOS        SLIDESHARES MarketResearch.com_H_235pxw        BLOG        

   MARKET RESEARCH INSIGHTS & BUSINESS INTELLIGENCE

Cade Hildreth

Recent Posts

Major Market Forces Affecting the Cord Blood Industry

Posted by Cade Hildreth

Sep 11, 2015 8:53:41 AM

To compete in the global cord blood banking marketplace, you need to be informed about major market forces, including clinical trial data supporting applications for hematopoietic stem cells (HSCs) from cord blood and mesenchymal stem cells (MSCs) from cord tissue. Within this rapidly evolving industry, those who choose to commit to understanding current conditions will be positioned for a substantial strategic advantage.

Because the global cord blood banking industry has matured substantially over the past few years, new market forces have created both serious threats and novel opportunities. Read on to learn more.

Read More

Topics: Biotechnology

An Investor’s Guide to Understanding Market Variation within the Global Cord Blood Industry

Posted by Cade Hildreth

Jul 2, 2015 9:00:00 AM

Market Variation within the Global Cord Blood Industry

Cord blood banks now exist within nearly every developed country, as well within most developing nations. However, there is still significant variation within the industry. First, there is the divide between private and public cord blood banking, in which private companies serve individual families, while public banks serve the broader population. Additionally, some cord blood banks receive only units from nearby hospitals and birthing centers, while others allow mail-in units from a diverse geographic region.
Read More

Topics: Diagnostics, Biotechnology

Trends, Forces, & Landmark Events within the Induced Pluripotent Stem Cell Product Market

Posted by Cade Hildreth

May 20, 2015 9:00:00 AM

Because induced pluripotent stem cells (iPSCs) were discovered in 2006, the global market for iPSC products celebrated its 10th year of existence this year in 2015. Therefore, it is valuable to consider market conditions that have emerged over the previous 10 years, as well as new trends and projections that will affect the industry over the coming five years.

Read More

Topics: Biotechnology

4 Key Metrics You Need to Know to Invest in the Cord Blood Sector

Posted by Cade Hildreth

Mar 11, 2015 9:00:00 AM

The cord blood banking market has matured substantially over the past few years, creating new threats for market participants, as well as novel investment opportunities. Serious threats to the industry include new accreditation requirements that have increased the cost structure of cord blood banks, expensive cord blood transplantation procedures, difficulty with educating obstetricians about cellular therapies, and more.

Read More

Topics: Biotechnology

The Technical, Legal, and Political Minefield of Commercializing Stem Cells

Posted by Cade Hildreth

Jan 29, 2015 9:00:00 AM

Stem cells are primitive cells found in all multi-cellular organisms and are characterized by self-renewal and the capacity to differentiate into any mature cell type. However, it is this primitive nature that intrinsically makes commercializing stem cells a technical, legal and political minefield.

Read More

Topics: Biotechnology

Cord Blood Industry: Key Benchmarks to Track (and Why You Should Care)

Posted by Cade Hildreth

Dec 4, 2014 9:00:00 AM

Recently released, the “Complete 2015-16 Global Cord Blood Banking Industry Report” reveals key benchmarks to track and why you should care. Benchmarks are critical to assess, because the global cord blood market has matured substantially over the past few years, creating both serious threats and novel opportunities. 

Therefore, judging individual company performance relative to the broader cord blood marketplace has become substantially more complex.

Read More

Topics: Biotechnology

Induced Pluripotent Stem Cells (iPSC): 3 Major Market Forces (And Why You Should Care)

Posted by Cade Hildreth

Oct 28, 2014 9:47:00 AM

The induced pluripotent stem cell (iPSC) market first emerged in 2006, when iPSC technology was pioneered by Shinya Yamanaka’s lab at Kyoto University in Japan. The shocking discovery that the introduction of four transcription factors into adult cells could convert them into pluripotent stem cells sent waves of excitement throughout the scientific community. This landmark event came to represent one of the greatest stem cell research discoveries of all time and was memorialized in 2012, when Dr. Yamanaka and Sir John Gurdon were awarded the Nobel Prize "for the discovery that mature cells can be reprogrammed to become pluripotent.” 

Read More

Topics: Biotechnology

The Business of Commercializing Induced Pluripotent Stem Cells (iPSCs)

Posted by Cade Hildreth

Sep 3, 2014 9:00:00 AM

As a provider of stem cell products and technologies, you need to make effective product development decisions, generate improved revenues, and take market share from your competition. To do this, you need to be educated about prevailing market conditions. This involves knowing which stem cell types are showing the most promise and understanding methods through which they could be commercialized.

Stem cells are still a relatively new discovery, as the first stem cells were discovered in human cord blood in 1978, the first mouse embryonic stem cells were derived in 1981, and it was not until 2006 that induced pluripotent stem cells (iPSCs) were produced for the first time.

Read More

Topics: Biotechnology

Is Your Business Intelligence Provider Utilizing Futuristic Market Research Techniques?

Posted by Cade Hildreth

Jul 15, 2014 9:00:00 AM

Futuristic, the adjective, means “having or involving very modern technology or design.” The term was once used to describe how the world would be centuries down the road. Yet, we now find ourselves living right in the midst of futuristic times. As with many areas that revolutionize along with technological advances, the term, futuristic, has become a staple in the area of market research methodologies. Indeed, 2014 has never seen more opportunity for analysis of data. The total global amount of data is now estimated at approximately 4 zettabytes, with a zettabyte being 1000^7th bytes. As such, techniques for managing analysis of this massive global population of data must dynamically evolve as well.

Read More

Topics: Market Research Strategy, Market Research Provider

Market Penetration Rates Revealed for U.S. Cord Blood Banking Industry

Posted by Cade Hildreth

May 7, 2014 9:00:00 AM

Cord blood banking is a profitable and rapidly growing industry. Ten years ago, there were only 23 cord blood banks worldwide; now, there are nearly 500, a 21-fold increase (2,100%) in the companies involved in the industry over the past decade. This rate of growth has generated enormous interest in the industry from venture capital funds, investment banks, and even individual investors, including Richard Branson—the billionaire business magnate and investor who now owns the Virgin Health Bank as one of his portfolio companies.

The key metrics, among others, that investors must know in order to profit from the cord blood banking sector are the current and historical market penetration rates. As the global leader in cord blood industry data, BioInformant was recently asked by the Wall Street Journal (a major U.S. news outlet) to provide data on market penetration rates for U.S. private cord blood banking since 2004, a 10-year historical analysis. Because this is a powerful question and the answer reveals critical market data, BioInformant is also sharing the findings with our readers.

Let’s dig into the numbers…

Read More

Topics: Biotechnology

Subscribe to our blog

Popular Categories

How-Tos

Industry Insights

New Call-to-action
How to Succeed Using Market Research, featured on www.blog.marketresearch.com